Search Results 161-170 of 15940 for pharmacogenetics
The purpose of this study is to identify common genetic variants contributing to the risk of glioma. Evaluate gene-gene and gene-environmental interactions with ...
About this study. The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients ...
About this study. The purpose of this research is to develop a better understanding of the cause of vascular overgrowth syndromes and to develop a ...
This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...
Drugs used in chemotherapy, such as fludarabine phosphate and cytarabine, work in different ways to stop the growth of cancer cells, either by killing the cells ...
Application and admissions information for the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.
When prescribing a medication for you, your physician considers many factors, including your age, sex, weight and current health conditions. Now, add to that ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
This study is designed to explore the experiences of individuals growing up with a genetic diagnosis of SCAs and their families. Participation eligibility.
Learn about how our experts use testing, genetic counseling and treatments to help people with a family history of heart disease at risk of heart attacks.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.